Sector in which the organization works:
Short description of the organization and its work to control and eliminate NTDs
In 1987, with many partners, MSD launched the MECTIZAN® (ivermectin) Donation Program (MDP), the first large-scale, comprehensive global health initiative of its kind. The MDP provides the drug MECTIZAN to treat onchocerciasis (river blindness) in countries where the disease is endemic and to prevent lymphatic filariasis in African countries where it coexists with onchocerciasis. Today, the MDP is recognized as one of the world’s most successful global healthcare collaborations, and one that continues to have significant positive impact on tens of millions of people.
MSD is one of the 20 original endorsers of the London Declaration
Mectizan Donation Program